DELOVELY JACKSON: Open Payments
NPI 1013370857 · CHICAGO HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,688 in 21 payments from 12 companies in 2025. Trend: 2023 $58 · 2024 $152 · 2025 $1,688
Food & beverage: $1,688
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $438 |
| Gilead Sciences, Inc. | 3 | $314 |
| ABBVIE INC. | 4 | $306 |
| Alexion Pharmaceuticals, Inc. | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $121 |
| GENZYME CORPORATION | 1 | $114 |
| E.R. Squibb & Sons, L.L.C. | 1 | $92 |
| ALK-Abello, Inc | 1 | $80 |
| Dexcom, Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
Products named: EVENITY, LINZESS, DUPIXENT, VRAYLAR, Epclusa, COBENFY, Livdelzi, Odactra.
Industry payments across IL — which companies pay providers there.
